Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | SPNS2 | Q8IVW8 | 1/20 | 0.38 |
| ▸ | LPO | P22079 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.37 |
| ▸ | FNTB | P49356 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1299808 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL3664071 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL4240295 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL4067299 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL2231125 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL1526997 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL1898631 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL4060199 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL301893 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB | |
| SCHEMBL2403681 | 1.00 | TLR8 (0.44) | TLR8TLR7KMT2AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250196021-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-19 | — | — | US | claimed |
| WO-2025128828-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-06-19 | — | — | WO | claimed |
| CN-107427758-B | Separation using ionic liquid solvents | 切弗朗菲利浦化学公司 | 2020-11-20 | — | — | CN | claimed |
| WO-2019143802-A1 | DISSOLUTION OF CELLULOSE IN IONIC LIQUIDS | TEXAS TECH UNIVERSITY SYSTEM (US) | 2019-07-25 | — | — | WO | claimed |
| US-10227274-B2 | Separations with ionic liquid solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-03-12 | — | — | US | claimed |
| EP-3244987-A1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | Chevron Phillips Chemical Company LP (US) | 2017-11-22 | — | — | EP | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| WO-2010125302-A1 | USE OF IONIC LIQUID FOR THE PERMANENT SHAPING OF KERATINIC FIBRES | L'OREAL (FR) | 2010-11-04 | — | — | WO | claimed |
| EP-2027225-A2 | VAPOR COMPRESSION UTILIZING IONIC LIQUID AS COMPRESSOR LUBRICANT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-25 | — | — | EP | claimed |
| EP-2021276-A2 | PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007143051-A2 | VAPOR COMPRESSION UTILIZING IONIC LIQUID AS COMPRESSOR LUBRICANT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-12-13 | — | — | WO | claimed |
| WO-2007143055-A2 | PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-12-13 | — | — | WO | claimed |
| WO-2001081329-A1 | METHOD FOR THE PREPARATION OF CHIRAL EPOXIDES | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-11-01 | — | — | WO | claimed |
| US-20260015304-A1 | METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-01-15 | — | — | US | disclosed |
| US-12441671-B2 | Metal-containing ionic liquids with reduced viscosity | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-10-14 | — | — | US | disclosed |
| US-12365647-B2 | Method for preparing acrylonitrile dimer | LG CHEM, LTD. (KR) | 2025-07-22 | — | — | US | disclosed |
| WO-2002012171-A1 | METHOD FOR PREPARING CHIRAL COMPOUND BY ASYMMETRIC RING OPENING REACTIONS OF EPOXIDES | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2002-02-14 | — | — | WO | disclosed |
| WO-2001003211-A1 | HYDROPHOBIC IONIC SALTS AND NONAQUEOUS ELECTROLYTES | COVALENT ASSOCIATES, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| CN-1039264-C | Electrolytic solution and electrochemical element prepared therefrom | SANYO CHEMICAL IND LTD (JP) | 1998-07-22 | — | — | CN | disclosed |
| CN-1117323-A | Electrolytic solution and electrochemical element prepared therefrom | SANYO CHEMICAL IND LTD (JP) | 1996-02-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12365647-B2 | Method for preparing acrylonitrile dimer | ADH1C, ADH1A, PUF60 | TLR8 3280/4885TLR7 3068/4885KMT2A 4707/4885 |
| US-20260015304-A1 | METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY | EXOC3, ELL, IGF2BP2 | TLR8 3021/4885TLR7 2688/4885KMT2A 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.